Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.
2.

Disulfide bond assignment and identification of regions required for functional activity of oncostatin M.

Kallestad JC, Shoyab M, Linsley PS.

J Biol Chem. 1991 May 15;266(14):8940-5.

3.

Abrogation of the antiproliferative activity of oncostatin M by a monoclonal antibody.

Radka SF, Naemura JR, Shoyab M.

Cytokine. 1992 May;4(3):221-6.

PMID:
1379836
4.

Identification of a gp130 cytokine receptor critical site involved in oncostatin M response.

Olivier C, Auguste P, Chabbert M, Lelièvre E, Chevalier S, Gascan H.

J Biol Chem. 2000 Feb 25;275(8):5648-56.

5.

Structure-function analysis of the C-terminal segment of human interleukin-6.

Li X, Rock F, Chong P, Cockle S, Keating A, Ziltener H, Klein M.

J Biol Chem. 1993 Oct 25;268(30):22377-84.

6.

Structure-function analysis of human IL-6. Epitope mapping of neutralizing monoclonal antibodies with amino- and carboxyl-terminal deletion mutants.

Brakenhoff JP, Hart M, De Groot ER, Di Padova F, Aarden LA.

J Immunol. 1990 Jul 15;145(2):561-8.

PMID:
1694882
7.

Interactions between oncostatin M and the IL-6 signal transducer, gp130.

Liu J, Modrell B, Aruffo A, Scharnowske S, Shoyab M.

Cytokine. 1994 May;6(3):272-8.

PMID:
8054483
9.

Oncostatin M binds directly to gp130 and behaves as interleukin-6 antagonist on a cell line expressing gp130 but lacking functional oncostatin M receptors.

Sporeno E, Paonessa G, Salvati AL, Graziani R, Delmastro P, Ciliberto G, Toniatti C.

J Biol Chem. 1994 Apr 15;269(15):10991-5.

10.

Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor.

Liautard J, Sun RX, Cotte N, Gaillard JP, Mani JC, Klein B, Brochier J.

Cytokine. 1997 Apr;9(4):233-41.

PMID:
9112331
11.
12.

Identification of ligand-binding site III on the immunoglobulin-like domain of the granulocyte colony-stimulating factor receptor.

Layton JE, Hall NE, Connell F, Venhorst J, Treutlein HR.

J Biol Chem. 2001 Sep 28;276(39):36779-87. Epub 2001 Jul 23.

13.
14.
15.

Identification of a 14-3-3 binding sequence in the common beta chain of the granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and IL-5 receptors that is serine-phosphorylated by GM-CSF.

Stomski FC, Dottore M, Winnall W, Guthridge MA, Woodcock J, Bagley CJ, Thomas DT, Andrews RK, Berndt MC, Lopez AF.

Blood. 1999 Sep 15;94(6):1933-42.

16.

Identification of an interleukin-15alpha receptor-binding site on human interleukin-15.

Bernard J, Harb C, Mortier E, Quéméner A, Meloen RH, Vermot-Desroches C, Wijdeness J, van Dijken P, Grötzinger J, Slootstra JW, Plet A, Jacques Y.

J Biol Chem. 2004 Jun 4;279(23):24313-22. Epub 2004 Mar 23.

17.

Epitope mapping of a C5a neutralizing mAb using a combined approach of phage display, synthetic peptides and site-directed mutagenesis.

Kola A, Baensch M, Bautsch W, Hennecke M, Klos A, Casaretto M, Köhl J.

Immunotechnology. 1996 Jun;2(2):115-26.

PMID:
9373320
18.
20.

Detection of oncostatin M in human plasma and serum by a sensitive enzyme immunoassay.

Naemura JR, Radka SF.

Lymphokine Cytokine Res. 1993 Jun;12(3):187-90.

PMID:
8347766

Supplemental Content

Support Center